Seer Insights Program

Advancing Translational and Development-Stage Proteomics

Seer Insights Program supports researchers and development teams seeking deeper biological insight through unbiased proteomics.

This initiative includes two distinct pathways designed to support both translational discovery and development-stage programs.

Choose the pathway that best fits your research or development needs

Explore Translational Research Track Explore Biopharma Development Access Program

Choose Your Program Pathway

Academic Translational Research Track

For academic investigators advancing translational proteomics research with clear relevance to human health.

This track supports studies that bridge biological discovery and clinical relevance by generating deep proteomic insights that enable biomarker discovery, disease understanding, and translational application.

Selected investigators receive:

End-to-end access to Seer’s Proteograph^® workflow
High-depth mass spectrometry analysis
Dedicated scientific collaboration with Seer experts
Structured bioinformatics support to enable data interpretation

Ideal for:

Identifying protein biomarkers associated with disease or clinical outcomes
Investigating disease biology using patient-derived or translational cohorts
Generating datasets to support future translational or clinical studies

Selected projects will be supported through Seer’s Technology Access Center (STAC), with defined study scope including sample processing, proteomic analysis, and collaborative data review.

Learn More

Biopharma Development Access Program

For biotechnology and pharmaceutical teams seeking proteomic insight to inform development-stage programs particularly those without established in-house mass spectrometry proteomics capabilities.

This selective program is designed to support development-stage programs by generating deep, unbiased proteomic insights that inform critical pipeline decisions, including target validation, mechanism of action, resistance biology, and patient stratification.

Participants receive:

Dedicated Seer scientific partnership
Accelerated review timeline
Confidential participation option
Ownership of data and resulting intellectual property

Ideal for:

Investigating protein pathways in preclinical models to support target validation or IND-enabling biology
Comparing proteomic profiles between treatment responders and non-responders
Exploring circulating protein signatures linked to clinical outcomes

Selected teams receive access to Seer’s Proteograph^® workflow through the Seer Technology Access Center (STAC), enabling deep proteomic analysis to inform development decisions.

Learn More

About Seer Insights

Seer Insights is designed to accelerate the application of deep, unbiased proteomics across discovery and development.

Through access to Seer’s Proteograph^® workflow and the Seer Technology Access Center (STAC), participants can generate high-depth proteomic datasets that reveal biology inaccessible through conventional approaches.

Participants may receive support including:

Deep, unbiased proteomic profiling through the Proteograph^® workflow
High-resolution mass spectrometry analysis at scale
Collaborative data interpretation with Seer scientists
Structured support to translate proteomic data into biological insight

2026 Program Timeline

April 19, 2026
Program launch and submission window opens
June 12, 2026
Submission deadline
End of June 2026
Program selections announced

Frequently Asked Questions

Seer Insights is a two-track initiative designed to advance proteomics from discovery to development. The program includes:

The Translational Research Track, supporting academic translational investigators bridging biological discovery to clinical, therapeutic, or applied health relevance.
The Biopharma Development Access Program, supporting biotech and pharmaceutical teams generating decision-enabling proteomics data for development-stage programs.

Both tracks provide access to Seer’s Proteograph^® Product Suite through the Seer Technology Access Center (STAC), along with mass spectrometry and bioinformatics support.

No. Each track has its own submission process designed for the needs of the respective audience.

Academic researchers submit a research proposal through an online application form.

Biopharma teams submit a short concept describing how proteomic analysis could inform a development-stage program.

Projects must align with the capabilities of Seer’s Proteograph^® technology. Compatible sample types include plasma, serum, and cerebrospinal fluid (CSF). Applicants are encouraged to review the Proteograph Product Suite page to confirm technical alignment prior to submission. Detailed eligibility and submission information is available on each program track page.

The Seer Insights program is designed for researchers and development teams who do not have established in-house mass spectrometry-based proteomics capabilities and are seeking to incorporate deep proteomic analysis into their work.

Selected Research Highlights

Studies Enabled Through Seer Insights

The Seer Insights initiative has supported research across a range of disease areas, enabling investigators to uncover novel biology through deep proteomic analysis.

Explore selected research highlights generated through Seer Insights programs.